Edwin Posadas, MD FACP
Cedars-Sinai Medical Center · Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Edwin Posadas, MD FACP as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:04 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT05567679 · A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate CancerEdwin Posadas, MD · withdrawn · Prostate Cancer · principal investigator
- Ph2NCT05534646 · Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate CancEdwin Posadas, MD · recruiting · Castration-resistant Prostate Cancer · principal investigator
- Ph2NCT03418324 · Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on TherapyCedars-Sinai Medical Center · completed · Prostate Cancer · principal investigator
- Ph2NCT01834651 · A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral MetastasesEdwin Posadas, MD · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.